Active Pharmaceutical Ingredients Market Expected to Reach $308.48 Billion by 2026 | Ranbaxy Laboratories, Pfizer, Novartis, Mylan N.V, Lupin

According to Publisher, the Global Active Pharmaceutical Ingredients Market is accounted for $151.89 billion in 2017 and is expected to reach $308.48 billion by 2026 growing at a CAGR of 8.2% from 2017 to 2026. Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth.

Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

Get Sample Copy at https://www.reportsweb.com/inquiry&RW00012276332/sample

Some of the key players in Active Pharmaceutical Ingredients market include Teva Active Pharmaceutical Industries Limited, Ranbaxy Laboratories, Pfizer, Inc, Novartis, Mylan N.V, Lupin, Dr. Reddy's Lab, Boehringer Ingelheim GmbH, Aurobindo pharma, Albemarle Corporation, Ceva Animal Health, Inc., Virbac, Sun Pharmaceutical Industries Ltd., Merck Animal Health (U.S.), Elanco Animal Health (U.S.), Zoetis (U.S.), Merial Inc. (Sanofi) (France), Bioniche Animal Health (Canada), Bayer Healthcare (Germany), ELI Lilly and Company, Glaxosmithkline PLC, Abbvie Inc., Sanofi and Bristol-Myers Squibb.

Drug Types Covered:
-Generic Prescription
-Innovative Drugs
-Over-the-counter (OTC) Drugs
-Prescription Drugs
-Potency

API Formulations Covered:
-Innovative API
-Generic API

Type of Manufacturers Covered:
-Contract Manufacturers
-Captive Manufacturers
-Merchant API Manufacturers

Amongst Customer Base, Generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase. By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.

Make an Inquiry https://www.reportsweb.com/inquiry&RW00012276332/buying

Table of Contents
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Active Pharmaceutical Ingredients Market, By Drug Type
6 Global Active Pharmaceutical Ingredients Market, By API Formulation
7 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer
8 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis
9 Global Active Pharmaceutical Ingredients Market, By API Type
10 Global Active Pharmaceutical Ingredients Market, By Molecule
11 Global Active Pharmaceutical Ingredients Market, By Application
12 Global Active Pharmaceutical Ingredients Market, By Geography
13 Key Developments
14 Company Profiling

Regions Covered:
-North America
-Europe
-Asia Pacific
-South America
-Middle East & Africa

What our report offers:
-Market share assessments for the regional and country level segments
-Market share analysis of the top industry players
-Strategic recommendations for the new entrants
-Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
-Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
-Strategic recommendations in key business segments based on the market estimations
-Competitive landscaping mapping the key common trends
-Company profiling with detailed strategies, financials, and recent developments
-Supply chain trends mapping the latest technological advancements

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Pune, India

This release was published on openPR.